United States was Dexcom’s largest region in fiscal 2025, bringing in $3.33B of $4.66B (72%).
| Geography | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $2.14B | $2.63B | $2.89B | $3.33B | ||||||||
| International | $767.80M | $997.00M | $1.14B | $1.33B | ||||||||
| Outside Of The United States | — | — | — | — | ||||||||
| Total | $2.91B | $3.62B | $4.03B | $4.66B |
Dexcom brought in $4.66B from its two regions in fiscal 2025, the year ended December 31, 2025. That was up 15.6% from $4.03B in fiscal 2024. United States was the largest at $3.33B (71.5%), ahead of International at $1.33B (28.5%).
Compared with fiscal 2024, International grew 16.1% to $1.33B and United States grew 15.4% to $3.33B. From fiscal 2022 to 2025, combined revenue from these regions grew from $2.91B to $4.66B, a compound annual growth rate of 17.0%. United States' share of the total fell from 73.6% to 71.5%.
Distributor was Dexcom’s largest revenue line in fiscal 2025, bringing in $3.96B of $4.66B (85%).
| Contract with Customer, Sales Channel | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Distributor | $2.47B | $3.10B | $3.43B | $3.96B | ||||||
| Direct | $439.00M | $526.70M | $602.90M | $703.00M | ||||||
| Total | $2.91B | $3.62B | $4.03B | $4.66B |
Dexcom brought in $4.66B from its two revenue lines in fiscal 2025, the year ended December 31, 2025. That was up 15.6% from $4.03B in fiscal 2024. Distributor was the largest at $3.96B (84.9%), ahead of Direct at $703.00M (15.1%).
Compared with fiscal 2024, Direct grew 16.6% to $703.00M and Distributor grew 15.4% to $3.96B. From fiscal 2022 to 2025, combined revenue from these revenue lines grew from $2.91B to $4.66B, a compound annual growth rate of 17.0%. Distributor's share held steady at about 84.9%.
Dexcom (DXCM) reports its revenue by geography and by contract with customer, sales channel. In fiscal 2025, United States was its largest region, bringing in $3.33B (71.5% of the total), followed by International at $1.33B (28.5%).
United States was Dexcom's largest region in fiscal 2025, bringing in $3.33B, or 71.5% of the $4.66B total across its two regions.
Distributor was Dexcom's largest revenue line in fiscal 2025, bringing in $3.96B, or 84.9% of the $4.66B total across its two revenue lines.
International grew faster than United States in fiscal 2025, up 16.1% from $1.14B to $1.33B. United States grew 15.4% to $3.33B.
Every figure comes from Dexcom's annual financial filings, as reported. Each line keeps the name Dexcom gives it, and years follow its fiscal calendar.
Dexcom's revenue by geography goes back to fiscal 2014, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.